INTEGRILIN Side Effects

7021477-1 | Abdominal Pain, Asthenia, Collapse Of Lung, Headache, Hepatic Failure, Oedema Mouth, Pharyngeal Oedema, Renal Failure
on Sep 15, 2010 Female patient from UNITED STATES , 76 years of age, weighting 139.0 lb, was diagnosed with catheterisation cardiac and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), asthenia, collapse of lung, headache (What is headache?), hepatic failure, oedema mouth, pharyngeal oedema, renal failure. Integrilin dosage: 75 Mg; Iv. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HEPARIN SODIUM INJECTION 0.45% SODIUM CHLORIDE IN PLASTIC CONTAINER (25000 Iu; Indrp) (View Heparin Sodium Injection 0.45% Sodium Chloride In Plastic Container Review and Heparin Sodium Injection 0.45% Sodium Chloride In Plastic Container Label ), ENOXAPARIN SODIUM (60 Mg; Bid; Sc) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CENTRUM (View Centrum Review and Centrum Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), CALCIUM (View Calcium Review and Calcium Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ).

7006996-6 | Cardiac Tamponade, Gastric Haemorrhage, Haemodynamic Instability, Renal Haemorrhage
Patient was taking Integrilin (View Usage). Patient had the following side effects: cardiac tamponade, gastric haemorrhage, haemodynamic instability, renal haemorrhage on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 170.0 lb, was diagnosed with stent placement and. Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6769112-1 | Phlebitis
Adverse event was reported on May 25, 2010 by a Male patient taking Integrilin (View Usage) (Dosage: 180 Mcg/kg; ; Iv) was diagnosed with acute myocardial infarction and. Location: ISRAEL , 56 years of age, After Integrilin was administered, patient had the following side effects: phlebitis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ).

6754489-3 | Deep Vein Thrombosis, Dialysis, Disseminated Intravascular Coagulation, Hepatic Ischaemia, Multi-organ Failure, Overdose, Thrombocytopenia
on May 24, 2010 Male patient from UNITED STATES , 73 years of age, was diagnosed with catheterisation cardiac and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), dialysis (What is dialysis?), disseminated intravascular coagulation, hepatic ischaemia, multi-organ failure, overdose, thrombocytopenia. Integrilin dosage: Iv. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized and became disabled.


6742839-3 | Deep Vein Thrombosis, Dialysis, Disseminated Intravascular Coagulation, Ischaemic Hepatitis, Multi-organ Failure, Overdose, Thrombocytopenia
on May 18, 2010 Male patient from UNITED STATES , 73 years of age, was diagnosed with catheterisation cardiac and was treated with Integrilin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), dialysis (What is dialysis?), disseminated intravascular coagulation, ischaemic hepatitis, multi-organ failure, overdose, thrombocytopenia. Integrilin dosage: Iv. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized and became disabled.

6712496-0 | Incorrect Dose Administered, Product Packaging Issue
Patient was taking Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: incorrect dose administered, product packaging issue on May 05, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 220.1 lb, . Integrilin dosage: Iv Drip.

6632098-4 | Agitation, Confusional State, Haemorrhage Intracranial
Adverse event was reported on Mar 05, 2010 by a Female patient taking Integrilin (View Usage) (Dosage: ) . Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: agitation, confusional state, haemorrhage intracranial.

6622123-9 | Cardiogenic Shock, Haematocrit Decreased, Haemoglobin Decreased, Ischaemic Hepatitis, Multi-organ Failure, Platelet Count Decreased, Post Procedural Haemorrhage, Sepsis
on Feb 26, 2010 Male patient from CANADA , 75 years of age, was treated with Integrilin (View Usage). Patient had the following side effects: cardiogenic shock, haematocrit decreased, haemoglobin decreased, ischaemic hepatitis, multi-organ failure, platelet count decreased, post procedural haemorrhage, sepsis (What is sepsis?). Integrilin dosage: Iv. During the same period patient was treated with PLAVIX (75.0 Mg;qd;po ; 600.0 Mg;once;po) (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), PROTAMINE SULFATE (View Protamine Sulfate Review and Protamine Sulfate Label ). Patient was hospitalized.

6618066-7 | Catheter Site Haemorrhage
on Feb 26, 2010 Female patient from CANADA , 78 years of age, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: catheter site haemorrhage. Integrilin dosage: Iv. During the same period patient was treated with ASPIRIN (80.0 Mg; Po) (View Aspirin Review and Aspirin Label ), LOVENOX (100,0 Mg; Sc) (View Lovenox Review and Lovenox Label ), PLAVIX (Po) (View Plavix Review and Plavix Label ), ALTACE (View Altace Review and Altace Label ), FLOVENT (View Flovent Review and Flovent Label ), LIPITOR (View Lipitor Review and Lipitor Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), PARIET (View Pariet Review and Pariet Label ). Patient was hospitalized.

6583308-3 | Cardiogenic Shock, Coronary Artery Occlusion, Coronary Artery Thrombosis, Multi-organ Failure, Product Quality Issue
Patient was taking Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, coronary artery occlusion, coronary artery thrombosis, multi-organ failure, product quality issue on Jan 25, 2010 from GERMANY Additional patient health information: Male patient , 71 years of age, was diagnosed with acute myocardial infarction and. Integrilin dosage: 19.4 M. Inbo. During the same period patient was treated with HEPARIN (7500 Iu Nbo) (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6583225-9 | Cardiogenic Shock, Coronary Artery Occlusion, Product Quality Issue
Adverse event was reported on Jan 27, 2010 by a Male patient taking Integrilin (View Usage) (Dosage: Inbo) . Location: GERMANY , 67 years of age, Patient had the following side effects: cardiogenic shock, coronary artery occlusion, product quality issue. During the same period patient was treated with HEPARIN (Nbo) (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6583216-8 | Cardiogenic Shock, Coronary Artery Occlusion, Coronary Artery Thrombosis, Product Quality Issue
on Jan 25, 2010 Male patient from GERMANY , 76 years of age, was diagnosed with percutaneous coronary intervention and was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: cardiogenic shock, coronary artery occlusion, coronary artery thrombosis, product quality issue. Integrilin dosage: 21 Ml, Inbo. During the same period patient was treated with HEPARIN (10000 Iu, Inbo) (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6568797-2 | Cardiogenic Shock, Coronary Artery Occlusion, Multi-organ Failure
on Jan 21, 2010 Male patient from GERMANY , 71 years of age, was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, coronary artery occlusion, multi-organ failure. Integrilin dosage: 19.4 Ml;inbo. During the same period patient was treated with HEPARIN (7500 Iu;inbo) (View Heparin Review and Heparin Label ).

6567060-3 | Cardiogenic Shock, Coronary Artery Occlusion
Patient was taking Integrilin (View Usage). Patient had the following side effects: cardiogenic shock, coronary artery occlusion on Jan 21, 2010 from GERMANY Additional patient health information: Male patient , 76 years of age, . Integrilin dosage: 21 Ml; Inbo. During the same period patient was treated with HEPARIN (10000 Iu; Inbo) (View Heparin Review and Heparin Label ).

6567058-5 | Cardiogenic Shock, Coronary Artery Occlusion
Adverse event was reported on Jan 21, 2010 by a Male patient taking Integrilin (View Usage) (Dosage: Inbo) . Location: GERMANY , 67 years of age, After Integrilin was administered, patient had the following side effects: cardiogenic shock, coronary artery occlusion. During the same period patient was treated with HEPARIN (Inbo) (View Heparin Review and Heparin Label ).

6556659-6 | Cardiogenic Shock, Coronary Artery Occlusion
on Jan 14, 2010 Male patient from GERMANY , 76 years of age, was diagnosed with coagulopathy and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, coronary artery occlusion. Integrilin dosage: 21 Ml. During the same period patient was treated with HEPARIN (10000 Iu) (View Heparin Review and Heparin Label ).

6556647-X | Cardiogenic Shock, Coronary Artery Occlusion
on Jan 14, 2010 Male patient from GERMANY , 67 years of age, was treated with Integrilin (View Usage). Patient had the following side effects: cardiogenic shock, coronary artery occlusion. Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6552897-7 | Cardiogenic Shock, Coronary Artery Occlusion, Multi-organ Failure
Patient was taking Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: cardiogenic shock, coronary artery occlusion, multi-organ failure on Jan 14, 2010 from GERMANY Additional patient health information: Male patient , 71 years of age, . Integrilin dosage: 21 Ml;. During the same period patient was treated with HEPARIN (7500 Iu;) (View Heparin Review and Heparin Label ).

6526393-7 | Catheter Site Discharge, Deep Vein Thrombosis, Myocardial Infarction, Petechiae, Thrombocytopenia, Thrombosis In Device
Adverse event was reported on Dec 22, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: ; Once; Iv) was diagnosed with angioplasty (What is angioplasty?) and. Location: UNITED STATES , 73 years of age, Patient experienced the following unwanted or unexpected effects: catheter site discharge, deep vein thrombosis (What is deep vein thrombosis?), myocardial infarction, petechiae, thrombocytopenia, thrombosis in device. During the same period patient was treated with UNFRACTIONATED HEPARIN (View Unfractionated Heparin Review and Unfractionated Heparin Label ).

6444535-9 | Infusion Site Haematoma, Infusion Site Pain, Infusion Site Swelling
on Nov 17, 2009 Male patient from UNITED STATES , weighting 165.3 lb, was diagnosed with postoperative care, stent placement and was treated with Integrilin (View Usage). Patient had the following side effects: infusion site haematoma, infusion site pain, infusion site swelling. Integrilin dosage: 2mcg/kg/min -12ml/hr- Continuous Infusio Iv. During the same period patient was treated with ASPIRIN TAB (View Aspirin Tab Review and Aspirin Tab Label ), PLAVIX (View Plavix Review and Plavix Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6429572-2 | Catheter Site Related Reaction, Haemorrhagic Disorder, Petechiae, Thrombocytopenia, Wound Secretion
on Oct 23, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with angioplasty (What is angioplasty?) and was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: catheter site related reaction, haemorrhagic disorder, petechiae, thrombocytopenia, wound secretion. Integrilin dosage: Once;iv. During the same period patient was treated with UNFRACTIONATED HEPARIN (View Unfractionated Heparin Review and Unfractionated Heparin Label ).

6429337-1 | Catheter Site Discharge, Gastrointestinal Haemorrhage, Petechiae, Thrombocytopenia
Patient was taking Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site discharge, gastrointestinal haemorrhage, petechiae, thrombocytopenia on Oct 23, 2009 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with acute coronary syndrome and. Integrilin dosage: Once;iv. During the same period patient was treated with UNFRACTIONATED HEPARIN (View Unfractionated Heparin Review and Unfractionated Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6429336-X | Catheter Site Discharge, Petechiae, Thrombocytopenia
Adverse event was reported on Oct 23, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: Iv) was diagnosed with vascular occlusion and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: catheter site discharge, petechiae, thrombocytopenia. During the same period patient was treated with UNFRACTIONATED HEPARIN (View Unfractionated Heparin Review and Unfractionated Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6429335-8 | Autoantibody Positive, Catheter Site Discharge, Haemorrhage Urinary Tract, Petechiae, Thrombocytopenia
on Oct 23, 2009 Female patient from UNITED STATES , 59 years of age, was diagnosed with coronary angioplasty and was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: autoantibody positive, catheter site discharge, haemorrhage urinary tract, petechiae, thrombocytopenia. Integrilin dosage: Once;iv; Once;iv. During the same period patient was treated with UNFRACTIONED HEPARIN (View Unfractioned Heparin Review and Unfractioned Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6429328-0 | Catheter Site Discharge, Petechiae, Thrombocytopenia
on Oct 23, 2009 Female patient from UNITED STATES , 81 years of age, was diagnosed with angioplasty (What is angioplasty?), myocardial infarction and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site discharge, petechiae, thrombocytopenia. Integrilin dosage: Once; Iv. During the same period patient was treated with UNFRACTIONED HEPARIN (View Unfractioned Heparin Review and Unfractioned Heparin Label ).

6429096-2 | Angina Unstable, Coronary Artery Disease, Coronary Artery Stenosis, Diffuse Alveolar Damage, Electrocardiogram St Segment Depression, Hypoxia, Lung Infiltration, Myocardial Infarction, Non-cardiogenic Pulmonary Oedema
Patient was taking Integrilin (View Usage). Patient had the following side effects: angina unstable, coronary artery disease (What is coronary artery disease?), coronary artery stenosis, diffuse alveolar damage, electrocardiogram st segment depression, hypoxia, lung infiltration, myocardial infarction, non-cardiogenic pulmonary oedema on Oct 22, 2009 from UNITED STATES Additional patient health information: Male patient , 82 years of age, was diagnosed with percutaneous coronary intervention and. Integrilin dosage: Once; Inbo; Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6407564-7 | Cardiac Failure, Circulatory Collapse, Thrombocytopenia
Adverse event was reported on Oct 06, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: 1 Df; 1 Df;) was diagnosed with myocardial infarction and. Location: GERMANY , 80 years of age, After Integrilin was administered, patient had the following side effects: cardiac failure, circulatory collapse, thrombocytopenia. During the same period patient was treated with ASS (CON.) (View Ass (con.) Review and Ass (con.) Label ), PLAVIX (CON.) (View Plavix (con.) Review and Plavix (con.) Label ).

6406600-1 | Cerebral Haemorrhage, Myocardial Infarction, Surgical Failure
on Oct 09, 2009 Male patient from FRANCE , 75 years of age, was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, myocardial infarction, surgical failure. Integrilin dosage: ;iv. During the same period patient was treated with ASPIRIN (;po) (View Aspirin Review and Aspirin Label ), PLAVIX (;po) (View Plavix Review and Plavix Label ). Patient was hospitalized.

6389054-3 | Blood Creatinine Increased, Cerebral Haemorrhage, Cerebral Thrombosis
on Sep 22, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with cardiac operation and was treated with Integrilin (View Usage). Patient had the following side effects: blood creatinine increased, cerebral haemorrhage, cerebral thrombosis. Integrilin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (; Po) (View Plavix Review and Plavix Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6387257-5 | Catheter Site Discharge, Petechiae, Thrombocytopenia
Patient was taking Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: catheter site discharge, petechiae, thrombocytopenia on Sep 14, 2009 from UNITED STATES Additional patient health information: Male patient , 73 years of age, . Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6387256-3 | Catheter Site Discharge, Gastrointestinal Haemorrhage, Petechiae, Thrombocytopenia
Adverse event was reported on Sep 14, 2009 by a Female patient taking Integrilin (View Usage) (Dosage: ) . Location: UNITED STATES , 79 years of age, Patient experienced the following unwanted or unexpected effects: catheter site discharge, gastrointestinal haemorrhage, petechiae, thrombocytopenia. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6381470-9 | Catheter Related Complication, Petechiae, Thrombocytopenia
on Sep 14, 2009 Male patient from UNITED STATES , 65 years of age, was treated with Integrilin (View Usage). Patient had the following side effects: catheter related complication, petechiae, thrombocytopenia. Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6380718-4 | Catheter Site Discharge, Haemorrhage Urinary Tract, Petechiae, Thrombocytopenia
on Sep 14, 2009 Female patient from UNITED STATES , 59 years of age, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: catheter site discharge, haemorrhage urinary tract, petechiae, thrombocytopenia. Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

6379213-8 | Catheter Site Related Reaction, Gastrointestinal Haemorrhage, Petechiae, Thrombocytopenia, Wound Secretion
Patient was taking Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site related reaction, gastrointestinal haemorrhage, petechiae, thrombocytopenia, wound secretion on Sep 14, 2009 from UNITED STATES Additional patient health information: Female patient , 79 years of age, . Integrilin dosage: . During the same period patient was treated with UNFRACTIONATED HEPARIN (CON.) (View Unfractionated Heparin (con.) Review and Unfractionated Heparin (con.) Label ).

6379190-X | Haemorrhage, Petechiae, Thrombocytopenia, Wound Secretion
Adverse event was reported on Sep 14, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: ) . Location: UNITED STATES , 73 years of age, Patient had the following side effects: haemorrhage, petechiae, thrombocytopenia, wound secretion. During the same period patient was treated with UNFRACTIONATED HEPARIN (CON.) (View Unfractionated Heparin (con.) Review and Unfractionated Heparin (con.) Label ).

6378799-7 | Catheter Site Discharge, Petechiae, Thrombocytopenia
on Sep 14, 2009 Female patient from UNITED STATES , 81 years of age, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: catheter site discharge, petechiae, thrombocytopenia. Integrilin dosage: . During the same period patient was treated with UNFRACTIONED HEPARIN (View Unfractioned Heparin Review and Unfractioned Heparin Label ).

6337083-8 | Chest Pain, Electrocardiogram St Segment Elevation, Thrombosis
on Aug 21, 2009 Male patient from UNITED STATES , 50 years of age, was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), electrocardiogram st segment elevation, thrombosis. Integrilin dosage: Inbo; Indrp. Patient was hospitalized.

6288946-3 | Cardio-respiratory Arrest, Convulsion, Haemothorax, Pleural Effusion, Retroperitoneal Haemorrhage, Unresponsive To Stimuli
Patient was taking Integrilin (View Usage). Patient had the following side effects: cardio-respiratory arrest, convulsion, haemothorax, pleural effusion, retroperitoneal haemorrhage, unresponsive to stimuli on Jul 23, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with coronary artery disease (What is coronary artery disease?), stent placement and. Integrilin dosage: 5.1 Ml/hour. During the same period patient was treated with HEPARIN UPSTREAM (Unk) (View Heparin Upstream Review and Heparin Upstream Label ), ANGIOMAX (12.5ml Bolus Then 5mg/ml Infusion) (View Angiomax Review and Angiomax Label ), PLAVIX (View Plavix Review and Plavix Label ).

6287747-X | Thrombocytopenia
Adverse event was reported on Feb 02, 2009 by a Female patient taking Integrilin (View Usage) (Dosage: 2 Mcg;iv ; 180 Mcg;iv ; 90 Mcg;iv) . Location: UNITED STATES , 68 years of age, After Integrilin was administered, patient had the following side effects: thrombocytopenia. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), REMICADE (View Remicade Review and Remicade Label ), IMURAN (View Imuran Review and Imuran Label ), WELCHOL (View Welchol Review and Welchol Label ).

6287745-6 | Thrombocytopenia
on Jan 27, 2009 Male patient from UNITED STATES , 70 years of age, was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Integrilin dosage: .

6287743-2 | Platelet Count Decreased, Thrombocytopenia
on Jan 23, 2009 Male patient from UNITED STATES , 70 years of age, was treated with Integrilin (View Usage). Patient had the following side effects: platelet count decreased, thrombocytopenia. Integrilin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6287707-9 | Haemorrhage Intracranial
Patient was taking Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: haemorrhage intracranial on Mar 09, 2009 from UNITED STATES Additional patient health information: Male patient , 57 years of age, . Integrilin dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6287702-X | Epistaxis, Vomiting
Adverse event was reported on Apr 21, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: ) was diagnosed with stent placement and. Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: epistaxis, vomiting.

6287697-9 | Pulmonary Haemorrhage
on Jul 02, 2008 Female patient from UNITED STATES , 67 years of age, was treated with Integrilin (View Usage). Patient had the following side effects: pulmonary haemorrhage. Integrilin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), HEPARIN (View Heparin Review and Heparin Label ).

6287694-3 | Gastrointestinal Haemorrhage, Underdose
on Jun 30, 2008 Female patient from UNITED STATES , weighting 275.6 lb, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: gastrointestinal haemorrhage, underdose. Integrilin dosage: 2 Mg. Patient was hospitalized.

6287688-8 | Cerebral Infarction, Rash, Subarachnoid Haemorrhage
Patient was taking Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, rash (What is rash?), subarachnoid haemorrhage on Jan 13, 2009 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 162.0 lb, was diagnosed with catheterisation cardiac and. Integrilin dosage: Once;inbo. During the same period patient was treated with HEPARIN SODIUM (1000 Ml;iv ; Iv ; 1000 Ml;iv) (View Heparin Sodium Review and Heparin Sodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6287685-2 | Pulmonary Haemorrhage, Thrombocytopenia
Adverse event was reported on Jan 15, 2009 by a Male patient taking Integrilin (View Usage) (Dosage: ) . Location: UNITED STATES , 60 years of age, Patient had the following side effects: pulmonary haemorrhage, thrombocytopenia. Patient was hospitalized.

6287678-5 | Haemorrhage, Overdose
on Feb 20, 2009 Male patient from UNITED STATES , 85 years of age, was treated with Integrilin (View Usage). After Integrilin was administered, patient had the following side effects: haemorrhage, overdose. Integrilin dosage: 180 Mcg/kg;imbo.

6287666-9 | Haemorrhage, Thrombocytopenia
on Mar 13, 2009 Female patient from UNITED STATES , 60 years of age, was diagnosed with myocardial infarction and was treated with Integrilin (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage, thrombocytopenia. Integrilin dosage: .

6287663-3 | Thrombocytopenia
Patient was taking Integrilin (View Usage). Patient had the following side effects: thrombocytopenia on Jul 11, 2008 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 200.0 lb, was diagnosed with angioplasty (What is angioplasty?) and. Integrilin dosage: Iv. During the same period patient was treated with HEPARIN (Incor) (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CRESTOR (View Crestor Review and Crestor Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.